Precision Optics Corporation, Inc. (POCI)
USD 5.01
(0.2%)
USD 5.01
(0.2%)
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2024 | 3.43 Million USD | 8.71% |
| 2023 | 3.15 Million USD | 5.35% |
| 2022 | 2.99 Million USD | 1090.11% |
| 2021 | 251.99 Thousand USD | -75.17% |
| 2020 | 1.01 Million USD | 6852.09% |
| 2019 | 14.59 Thousand USD | -38.04% |
| 2018 | 23.56 Thousand USD | -26.26% |
| 2017 | 31.95 Thousand USD | -19.74% |
| 2016 | 39.81 Thousand USD | 0.0% |
| 2015 | - USD | 0.0% |
| 2014 | - USD | 0.0% |
| 2013 | - USD | -100.0% |
| 2012 | 51.25 Thousand USD | -93.44% |
| 2011 | 780.83 Thousand USD | 8.32% |
| 2010 | 720.83 Thousand USD | 55.32% |
| 2009 | 464.1 Thousand USD | 4404.11% |
| 2008 | 10.3 Thousand USD | 0.0% |
| 2007 | - USD | 0.0% |
| 2006 | - USD | 0.0% |
| 2005 | - USD | 0.0% |
| 2004 | - USD | -100.0% |
| 2003 | 5381.00 USD | -89.5% |
| 2002 | 51.24 Thousand USD | -57.43% |
| 2001 | 120.39 Thousand USD | -34.6% |
| 2000 | 184.1 Thousand USD | -38.63% |
| 1999 | 300 Thousand USD | 0.0% |
| 1998 | 300 Thousand USD | 0.0% |
| 1997 | 300 Thousand USD | 0.0% |
| 1996 | 300 Thousand USD | 200.0% |
| 1995 | 100 Thousand USD | 0.0% |
| 1994 | 100 Thousand USD | 0.0% |
| 1993 | - USD | 0.0% |
| 1992 | - USD | -100.0% |
| 1991 | 200 Thousand USD | 0.0% |
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2024 Q1 | 2.97 Million USD | -5.7% |
| 2024 Q3 | 3.01 Million USD | 7.8% |
| 2024 Q2 | 2.79 Million USD | -6.07% |
| 2024 Q4 | 3.43 Million USD | 13.85% |
| 2023 Q2 | 2.71 Million USD | -4.95% |
| 2023 Q1 | 2.85 Million USD | -4.7% |
| 2023 FY | 3.15 Million USD | 5.35% |
| 2023 Q3 | 2.57 Million USD | -5.24% |
| 2023 Q4 | 3.15 Million USD | 22.73% |
| 2022 Q3 | 2.72 Million USD | 0.29% |
| 2022 FY | 2.99 Million USD | 1090.11% |
| 2022 Q1 | 227.61 Thousand USD | -9.67% |
| 2022 Q2 | 2.71 Million USD | 1093.09% |
| 2022 Q4 | 2.99 Million USD | 10.11% |
| 2021 Q3 | 275.78 Thousand USD | -70.81% |
| 2021 Q4 | 251.99 Thousand USD | -8.63% |
| 2021 FY | 251.99 Thousand USD | -75.17% |
| 2021 Q1 | 979.97 Thousand USD | -3.45% |
| 2021 Q2 | 944.75 Thousand USD | -3.59% |
| 2020 FY | 1.01 Million USD | 6852.09% |
| 2020 Q1 | 170.95 Thousand USD | 1071.01% |
| 2020 Q2 | 155.32 Thousand USD | -9.15% |
| 2020 Q3 | 240.43 Thousand USD | 54.8% |
| 2020 Q4 | 1.01 Million USD | 322.12% |
| 2019 FY | 14.59 Thousand USD | -38.04% |
| 2019 Q4 | 14.59 Thousand USD | -13.6% |
| 2019 Q1 | 21.37 Thousand USD | -9.27% |
| 2019 Q2 | 19.15 Thousand USD | -10.39% |
| 2019 Q3 | 16.89 Thousand USD | -11.79% |
| 2018 Q4 | 23.56 Thousand USD | -8.36% |
| 2018 FY | 23.56 Thousand USD | -26.26% |
| 2018 Q1 | 29.9 Thousand USD | -6.4% |
| 2018 Q2 | 27.82 Thousand USD | -6.96% |
| 2018 Q3 | 25.71 Thousand USD | -7.6% |
| 2017 Q3 | 33.96 Thousand USD | -5.51% |
| 2017 Q2 | 35.94 Thousand USD | -5.14% |
| 2017 FY | 31.95 Thousand USD | -19.74% |
| 2017 Q1 | 37.89 Thousand USD | -4.81% |
| 2017 Q4 | 31.95 Thousand USD | -5.93% |
| 2016 Q3 | 41.69 Thousand USD | 0.0% |
| 2016 Q1 | - USD | 0.0% |
| 2016 Q4 | 39.81 Thousand USD | -4.52% |
| 2016 FY | 39.81 Thousand USD | 0.0% |
| 2016 Q2 | - USD | 0.0% |
| 2015 Q1 | - USD | 0.0% |
| 2015 Q4 | - USD | 0.0% |
| 2015 Q3 | - USD | 0.0% |
| 2015 FY | - USD | 0.0% |
| 2015 Q2 | - USD | 0.0% |
| 2014 Q3 | - USD | 0.0% |
| 2014 Q4 | - USD | 0.0% |
| 2014 FY | - USD | 0.0% |
| 2014 Q2 | - USD | 0.0% |
| 2014 Q1 | - USD | 0.0% |
| 2013 Q2 | - USD | 0.0% |
| 2013 FY | - USD | -100.0% |
| 2013 Q4 | - USD | 0.0% |
| 2013 Q3 | - USD | 0.0% |
| 2013 Q1 | - USD | -100.0% |
| 2012 Q1 | 795.83 Thousand USD | 1.92% |
| 2012 Q3 | 68.81 Thousand USD | 1.85% |
| 2012 Q2 | 67.56 Thousand USD | -91.51% |
| 2012 FY | 51.25 Thousand USD | -93.44% |
| 2012 Q4 | 51.25 Thousand USD | -25.53% |
| 2011 FY | 780.83 Thousand USD | 8.32% |
| 2011 Q2 | 750.83 Thousand USD | 2.04% |
| 2011 Q1 | 735.83 Thousand USD | 2.08% |
| 2011 Q3 | 765.83 Thousand USD | 2.0% |
| 2011 Q4 | 780.83 Thousand USD | 1.96% |
| 2010 Q3 | 658.72 Thousand USD | 10.92% |
| 2010 FY | 720.83 Thousand USD | 55.32% |
| 2010 Q4 | 720.83 Thousand USD | 9.43% |
| 2010 Q2 | 593.85 Thousand USD | 12.26% |
| 2010 Q1 | 528.97 Thousand USD | 13.98% |
| 2009 Q4 | 464.1 Thousand USD | 16.25% |
| 2009 FY | 464.1 Thousand USD | 4404.11% |
| 2009 Q2 | 334.35 Thousand USD | 70.78% |
| 2009 Q3 | 399.22 Thousand USD | 19.4% |
| 2009 Q1 | 195.77 Thousand USD | 1800.03% |
| 2008 Q2 | - USD | 0.0% |
| 2008 Q3 | - USD | 0.0% |
| 2008 Q4 | 10.3 Thousand USD | 0.0% |
| 2008 Q1 | - USD | 0.0% |
| 2008 FY | 10.3 Thousand USD | 0.0% |
| 2007 Q3 | - USD | 0.0% |
| 2007 Q4 | - USD | 0.0% |
| 2007 FY | - USD | 0.0% |
| 2007 Q1 | - USD | 0.0% |
| 2007 Q2 | - USD | 0.0% |
| 2006 Q4 | - USD | 0.0% |
| 2006 Q2 | - USD | 0.0% |
| 2006 Q1 | - USD | 0.0% |
| 2006 FY | - USD | 0.0% |
| 2006 Q3 | - USD | 0.0% |
| 2005 FY | - USD | 0.0% |
| 2005 Q1 | - USD | 0.0% |
| 2005 Q3 | - USD | 0.0% |
| 2005 Q4 | - USD | 0.0% |
| 2005 Q2 | - USD | 0.0% |
| 2004 Q1 | 473.00 USD | -91.21% |
| 2004 FY | - USD | -100.0% |
| 2004 Q4 | - USD | 0.0% |
| 2004 Q3 | - USD | 0.0% |
| 2004 Q2 | - USD | -100.0% |
| 2003 FY | 5381.00 USD | -89.5% |
| 2003 Q4 | 5381.00 USD | -54.43% |
| 2003 Q3 | 11.8 Thousand USD | -32.68% |
| 2003 Q2 | 17.53 Thousand USD | -40.61% |
| 2003 Q1 | 29.53 Thousand USD | -42.38% |
| 2002 FY | 51.24 Thousand USD | -57.43% |
| 2002 Q4 | 51.24 Thousand USD | -26.04% |
| 2002 Q3 | 69.29 Thousand USD | -20.01% |
| 2002 Q2 | 86.63 Thousand USD | -3.95% |
| 2002 Q1 | 90.19 Thousand USD | -25.09% |
| 2001 Q2 | 170.83 Thousand USD | 15.65% |
| 2001 Q4 | 120.39 Thousand USD | -12.57% |
| 2001 FY | 120.39 Thousand USD | -34.6% |
| 2001 Q1 | 147.71 Thousand USD | -19.76% |
| 2001 Q3 | 137.71 Thousand USD | -19.38% |
| 2000 Q2 | 200 Thousand USD | -33.33% |
| 2000 FY | 184.1 Thousand USD | -38.63% |
| 2000 Q3 | 223.12 Thousand USD | 11.56% |
| 2000 Q1 | 300 Thousand USD | 0.0% |
| 2000 Q4 | 184.1 Thousand USD | -17.49% |
| 1999 Q4 | 300 Thousand USD | 0.0% |
| 1999 FY | 300 Thousand USD | 0.0% |
| 1999 Q1 | 300 Thousand USD | 0.0% |
| 1999 Q2 | 300 Thousand USD | 0.0% |
| 1999 Q3 | 300 Thousand USD | 0.0% |
| 1998 Q1 | 300 Thousand USD | 0.0% |
| 1998 Q4 | 300 Thousand USD | 0.0% |
| 1998 Q3 | 300 Thousand USD | -25.0% |
| 1998 Q2 | 400 Thousand USD | 33.33% |
| 1998 FY | 300 Thousand USD | 0.0% |
| 1997 Q2 | 300 Thousand USD | -25.0% |
| 1997 Q4 | 300 Thousand USD | 0.0% |
| 1997 FY | 300 Thousand USD | 0.0% |
| 1997 Q1 | 400 Thousand USD | 33.33% |
| 1997 Q3 | 300 Thousand USD | 0.0% |
| 1996 FY | 300 Thousand USD | 200.0% |
| 1996 Q3 | 400 Thousand USD | 300.0% |
| 1996 Q1 | 100 Thousand USD | 0.0% |
| 1996 Q2 | 100 Thousand USD | 0.0% |
| 1996 Q4 | 300 Thousand USD | -25.0% |
| 1995 Q3 | 100 Thousand USD | 0.0% |
| 1995 Q4 | 100 Thousand USD | 0.0% |
| 1995 Q2 | 100 Thousand USD | -50.0% |
| 1995 Q1 | 200 Thousand USD | 100.0% |
| 1995 FY | 100 Thousand USD | 0.0% |
| 1994 Q2 | - USD | 0.0% |
| 1994 Q3 | 100 Thousand USD | 0.0% |
| 1994 Q4 | 100 Thousand USD | 0.0% |
| 1994 FY | 100 Thousand USD | 0.0% |
| 1994 Q1 | - USD | 0.0% |
| 1993 Q3 | - USD | 0.0% |
| 1993 Q2 | - USD | -100.0% |
| 1993 Q1 | 200 Thousand USD | 0.0% |
| 1993 FY | - USD | 0.0% |
| 1993 Q4 | - USD | 0.0% |
| 1992 FY | - USD | -100.0% |
| 1992 Q4 | - USD | 0.0% |
| 1991 FY | 200 Thousand USD | 0.0% |
| 1991 Q4 | 200 Thousand USD | 0.0% |
| Name | Total Debt | Total Debt Difference |
|---|---|---|
| Akoya Biosciences, Inc. | 85.7 Million USD | 95.993% |
| AngioDynamics, Inc. | 5.91 Million USD | 41.927% |
| AtriCure, Inc. | 74.49 Million USD | 95.39% |
| Avinger, Inc. | 15.39 Million USD | 77.691% |
| Azenta, Inc. | 60.43 Million USD | 94.317% |
| BioLife Solutions, Inc. | 42.69 Million USD | 91.955% |
| The Cooper Companies, Inc. | 2.56 Billion USD | 99.866% |
| Daxor Corporation | 755.65 Thousand USD | -354.499% |
| Ekso Bionics Holdings, Inc. | 7.16 Million USD | 52.086% |
| Femasys Inc. | 6.7 Million USD | 48.746% |
| GlucoTrack, Inc. | 196 Thousand USD | -1652.276% |
| Harvard Bioscience, Inc. | 42.77 Million USD | 91.97% |
| Hologic, Inc. | 2.53 Billion USD | 99.864% |
| ICU Medical, Inc. | 1.7 Billion USD | 99.799% |
| Intuitive Surgical, Inc. | 89.8 Million USD | 96.175% |
| KORU Medical Systems, Inc. | 4.44 Million USD | 22.736% |
| LeMaitre Vascular, Inc. | 19.09 Million USD | 82.014% |
| Innovative Eyewear, Inc. | - USD | -Infinity% |
| Innovative Eyewear, Inc. | - USD | -Infinity% |
| Masimo Corporation | 970 Million USD | 99.646% |
| Microbot Medical Inc. | 231 Thousand USD | -1386.78% |
| Meihua International Medical Technologies Co., Ltd. | 7.33 Million USD | 53.152% |
| Merit Medical Systems, Inc. | 891.35 Million USD | 99.615% |
| Nephros, Inc. | 1.83 Million USD | -87.062% |
| NovoCure Limited | 596.24 Million USD | 99.424% |
| NEXGEL, Inc. | 2.79 Million USD | -22.747% |
| NEXGEL, Inc. | 2.79 Million USD | -22.747% |
| Singular Genomics Systems, Inc. | 75.28 Million USD | 95.438% |
| OraSure Technologies, Inc. | 13.5 Million USD | 74.567% |
| Pro-Dex, Inc. | 13.54 Million USD | 74.648% |
| Pulse Biosciences, Inc. | 9.14 Million USD | 62.44% |
| Predictive Oncology Inc. | 2.85 Million USD | -20.22% |
| QuidelOrtho Corporation | 2.61 Billion USD | 99.869% |
| Repligen Corporation | 711.8 Million USD | 99.517% |
| Sanara MedTech Inc. | 11.79 Million USD | 70.875% |
| STAAR Surgical Company | 35.83 Million USD | 90.416% |
| Sharps Technology, Inc. | - USD | -Infinity% |
| Utah Medical Products, Inc. | 342 Thousand USD | -904.228% |
| DENTSPLY SIRONA Inc. | 2.29 Billion USD | 99.851% |
| Jin Medical International Ltd. | 4.11 Million USD | 16.497% |